Abiopharma

🔍 Gotelli Robert (Executive)

Company: Bank of Marin Bancorp (BMRC)

Report Date: 2024-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2024-04-01 | Code: H | shares_owned_after: 36,460.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2024-04-01 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 17,151.05
• Holds 1,300 shares of Stock Options (Right to Buy) at $22.94 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2024-04-01 | Exercise: 2019-04-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 2,200 shares of Stock Options (Right to Buy) at $25.38 per share (Derivative)
  Date: 2025-03-02 | Code: H | Expires: 2025-03-02 | Exercise: 2018-03-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4
• Holds 2,400 shares of Stock Options (Right to Buy) at $24.83 per share (Derivative)
  Date: 2026-03-01 | Code: H | Expires: 2026-03-01 | Exercise: 2019-03-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5, F4
• Holds 1,560 shares of Stock Options (Right to Buy) at $34.8 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2027-03-01 | shares_owned_after: 1,560.00 | Footnotes: F4
• Holds 1,740 shares of Stock Options (Right to Buy) at $33.58 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2028-03-01 | shares_owned_after: 1,740.00 | Footnotes: F4
• Holds 980 shares of Stock Options (Right to Buy) at $33.58 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2028-03-01 | shares_owned_after: 980.00 | Footnotes: F6
• Holds 1,580 shares of Stock Options (Right to Buy) at $44.45 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2029-03-01 | shares_owned_after: 1,580.00 | Footnotes: F4
• Holds 1,770 shares of Stock Options (Right to Buy) at $40.1 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2030-03-02 | shares_owned_after: 1,770.00 | Footnotes: F4
• Holds 1,153 shares of Stock Options (Right to Buy) at $38.25 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2031-03-01 | shares_owned_after: 1,153.00 | Footnotes: F4
• Holds 1,429 shares of Stock Options (Right to Buy) at $38.11 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2031-10-29 | Exercise: 2021-10-29 | shares_owned_after: 1,429.00
• Holds 1,944 shares of Stock Options (Right to Buy) at $34.03 per share (Derivative)
  Date: 2024-04-01 | Code: H | Expires: 2032-03-01 | shares_owned_after: 1,944.00 | Footnotes: F4

Footnotes:

• F1: The stock option was granted on April 1, 2014 and vested in equal annual installments over five years, becoming fully exercisable on April 1, 2019. The option expired unexercised on April 1, 2024. This Form 4 is being filed late due to an administrative oversight.
• F2: Exercisable 20% per year beginning on first anniversary date of grant.
• F3: The stock option was granted on March 2, 2015 and vested in equal annual installments over three years, becoming fully exercisable on March 2, 2018. The option expired unexercised on March 2, 2025. This Form 4 is being filed late due to an administrative oversight.
• F4: Exercisable 33% per year beginning on first anniversary date of grant.
• F5: The stock option was granted on March 1, 2016 and vested in equal annual installments over three years, becoming fully exercisable on March 1, 2019. A portion of the option expired unexercised on April 1, 2024. The remaining portion of the option was previously exercised and reported on a Form 4 filed on March 3, 2026. This Form 4 is being filed late due to an administrative oversight.
• F6: Exercisable 33% per year beginning on first anniversary date of grant.